Td Private Client Wealth LLC Regeneron Pharmaceuticals, Inc. Transaction History

Td Private Client Wealth LLC

$4.44 Trillion
Q3 2025

A detailed history of Td Private Client Wealth LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 154 shares of REGN stock, worth $106,799. This represents 0.0% of its overall portfolio holdings.

Number of Shares

154

Previous 108 42.59%

Holding current value

$106,799

Previous $56.7 Million 52.72%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 27, 2025	BUY	$534.91 - $598.71 $24,605 - $27,540	46 Added 42.59%	154 $86.6 Million
Q2 2025 Jul 15, 2025	SELL	$483.07 - $625.6 $9,178 - $11,886	-19 Reduced 14.96%	108 $56.7 Million
Q1 2025 Apr 29, 2025	SELL	$634.14 - $744.83 $27,902 - $32,772	-44 Reduced 25.73%	127 $80.5 Million
Q4 2024 Feb 11, 2025	BUY	$701.85 - $1046.91 $10,527 - $15,703	15 Added 9.62%	171 $122 Million
Q3 2024 Nov 18, 2024	BUY	$1024.09 - $1201.76 $7,168 - $8,412	7 Added 4.7%	156 $164 Million

Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $131,596 - $159,607	149 New	149 $157 Million
Q1 2024 Aug 16, 2024	BUY	$902.69 - $993.35 $18,053 - $19,867	20 Added 14.6%	157 $151 Million
Q4 2023 Aug 16, 2024	BUY	$775.18 - $881.7 $3,875 - $4,408	5 Added 3.79%	137 $120 Million
Q3 2023 Aug 16, 2024	SELL	$692.45 - $844.37 $2,769 - $3,377	-4 Reduced 2.94%	132 $109 Million
Q2 2023 Aug 16, 2024	SELL	$700.03 - $830.35 $7,000 - $8,303	-10 Reduced 6.85%	136 $97.7 Million
Q1 2023 Aug 16, 2024	BUY	$680.49 - $826.97 $2,721 - $3,307	4 Added 2.82%	146 $120 Million
Q4 2022 Aug 16, 2024	SELL	$705.89 - $766.39 $4,941 - $5,364	-7 Reduced 4.7%	142 $102 Million
Q3 2022 Aug 16, 2024	BUY	$573.97 - $724.32 $18,941 - $23,902	33 Added 28.45%	149 $103 Million
Q2 2022 Aug 16, 2024	SELL	$548.35 - $738.84 $22,482 - $30,292	-41 Reduced 26.11%	116 $68.6 Million
Q1 2022 Aug 16, 2024	BUY	$595.12 - $698.43 $13,687 - $16,063	23 Added 17.16%	157 $110 Million
Q4 2021 Aug 16, 2024	BUY	$543.48 - $670.97 $20,652 - $25,496	38 Added 39.58%	134 $84.6 Million
Q3 2021 Aug 16, 2024	SELL	$574.03 - $680.96 $30,423 - $36,090	-53 Reduced 35.57%	96 $58.1 Million
Q2 2021 Aug 16, 2024	BUY	$472.8 - $558.54 $15,129 - $17,873	32 Added 12.8%	282 $158 Million
Q1 2021 Aug 16, 2024	BUY	$446.73 - $548.2 $37,078 - $45,500	83 Added 49.7%	250 $118 Million
Q4 2020 Aug 16, 2024	SELL	$478.3 - $607.98 $18,653 - $23,711	-39 Reduced 18.93%	167 $80.7 Million
Q3 2020 Aug 16, 2024	SELL	$544.75 - $658.21 $13,618 - $16,455	-25 Reduced 10.82%	206 $115 Million
Q2 2020 Aug 16, 2024	SELL	$493.32 - $643.92 $8,879 - $11,590	-18 Reduced 7.23%	231 $144 Million
Q1 2020 Aug 16, 2024	BUY	$336.18 - $494.43 $50,090 - $73,670	149 Added 149.0%	249 $122 Million
Q4 2019 Aug 16, 2024	SELL	$274.13 - $376.51 $13,432 - $18,448	-49 Reduced 32.89%	100 $37.5 Million

Others Institutions Holding REGN

# of Institutions

1,466

Shares Held

86.5M

Call Options Held

2.38M

Put Options Held

1.61M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.

Account

Td Private Client Wealth LLC Regeneron Pharmaceuticals, Inc. Transaction History